One of the key pathways implicated in SCLC is the ATR serine/threonine kinase (ATR)/checkpoint kinase 1 (CHK1) pathway, which is critical for activating both the S and G2/M checkpoints and promoting DNA repair. The gene discussed is CHEK1; the disease is small cell lung carcinoma.